GILTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANT, 1 fl. oz. (NDC 58552-122-01) and 8 fl. oz...

FDA Drug Recall #D-66207-001 — Class III — September 4, 2013

Recall Summary

Recall Number D-66207-001
Classification Class III — Low risk
Date Initiated September 4, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hi-Tech Pharmacal Co., Inc.
Location Amityville, NY
Product Type Drugs
Quantity 50,848 bottles (total for 3 lots)

Product Description

GILTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANT, 1 fl. oz. (NDC 58552-122-01) and 8 fl. oz. (NDC 58552-122-08), and EXACTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANT, 16 fl. oz. (NDC 58552-125-16) --- Manufactured for: GIL PHARMACEUTICAL CORP. PONCE, PUERTO RICO 00716

Reason for Recall

Subpotent; phenylephrine HCl

Distribution Pattern

Puerto Rico

Lot / Code Information

1 fl. oz. and 8 fl. oz.: Batch/Lot 615688 (exp. 06/2014) and Batch/Lot 617689 (exp. 11/2014); 16 fl. oz: Batch/Lot 615649 (exp. 05/2014).

Other Recalls from Hi-Tech Pharmacal Co., Inc.

Recall # Classification Product Date
D-0048-2015 Class II HydrOXYzine Hydrochloride Oral Solution, USP, 1... Apr 1, 2014
D-389-2014 Class III Acyclovir Oral Suspension, USP 200 mg/5 mL, Net... Oct 28, 2013
D-888-2013 Class III Clobetasol Propionate Cream, USP, 0.05%, 15 gra... Jul 25, 2013
D-603-2013 Class III HydrOXYzine Hydrochloride Oral Solution, USP, 1... Apr 30, 2013
D-418-2013 Class III BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg... Apr 8, 2013

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.